MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 77.21% to -33 cents per share on March 12

ADC Therapeutics SA ADCT Stock Earnings Reports
Q4'25
Est.
$-0.34
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.14
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.18
The last earnings report on November 10 showed earnings per share of -18 cents, beating the estimate of -36 cents. With 187.48K shares outstanding, the current market capitalization sits at 501.70M.
View a ticker or compare two or three
ADCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADCT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com